In summary, this study demonstrates that tumor markers Cyclin D1 and CD55 in A431 cells can be differentially modulated via activation of three ER subtypes, suggesting the involvement of ER signals in cancer cell progression. The gene discussed is CD55; the disease is neoplasm.